Head to head
Standard Nuclear vs Linde
Side-by-side on the measures that matter, with a plain-English read. Full detail: STDN · LIN
STDN
Standard Nuclear
8.14-9.66%
1-year price shape — not enough history yet
Quant Rating C · 0/100
vs
LIN
Linde
502.83-1.45%
1-year price shape — +25% over the period
Quant Rating C · 69/100
1-year performance, rebased to 100
Linde edges it on the scoreable measures. Linde has the highest Quant Rating (69); Linde pays the highest dividend yield; Linde earns the most per share.
| STDN | LIN | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Chemicals | Specialty Chemicals |
| Last price | 8.14 | 502.83 |
| Change today | -9.66% | -1.45% |
| 1-year return | -- | +24.8% |
| Market cap | $1.28B | $230.84B |
| 52-week range | 7.05 – 17.34 | 384.00 – 546.40 |
| Valuation | ||
| P/E (TTM) | -48.17 | 33.39 |
| P/E percentile, own 5-yr range | 94th | 57th |
| P/B | 4.71 | 5.86 |
| Dividend yield | 0.00% | 1.25% |
| Profitability & growth | ||
| EPS (TTM) | -0.10 | 14.61 |
| Net profit (TTM) | $-15.31M | $6.71B |
| Revenue (TTM) | -- | $36.24B |
| Provider revenue period date | 2026-06-29 | 2026-09-29 |
| Revenue growth (YoY) | +756.5% | +9.2% |
| Gross margin | -57.7% | 47.9% |
| Operating margin | -245.7% | 27.1% |
| Net margin | -222.3% | 19.3% |
| Free cash flow (TTM) | -- | $5.08B |
| Provider cash-flow period date | 2026-06-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 48.8% | 88.6% |
| Insider activity (12mo) | 16 buy / 8 sell | 27 buy / 16 sell |
| Short interest (% of float) | 1.9% | 1.4% |
| Analyst consensus | 100% buy (8) | 94% buy / 6% hold (16) |
| Analyst price target | $17 (+111%) | $570 (+13%) |
| StockVane view | ||
| StockVane Quant Rating | C (0) | C (69) |
| Company | ||
| Employees | 106 | 65,177 |
| Founded | 2024 | 2017 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.